Epidemiology of clinically suspected and laboratory-confirmed bloodstream infections at a South African neonatal unit
dc.contributor.author | Dramowski, Angela | en_ZA |
dc.contributor.author | Bekker, Adrie | en_Za |
dc.contributor.author | Cotton, Mark Frederic | en_ZA |
dc.contributor.author | Whitelaw, Andrew Christopher | en_ZA |
dc.contributor.author | Coffin, Susan | en_ZA |
dc.date.accessioned | 2023-03-20T07:46:21Z | en_ZA |
dc.date.available | 2023-03-20T07:46:21Z | en_ZA |
dc.date.issued | 2021-07 | en_ZA |
dc.description | CITATION: Dramowski A, Bekker A, Cotton MF, Whitelaw AC, Coffin S (2021) Epidemiology of clinically suspected and laboratory-confirmed bloodstream infections at a South African neonatal unit. J Infect Dev Ctries 15:943–952. doi. 10.3855/jidc.13971 | en_ZA |
dc.description | The original publication is available at:jidc.org | en_ZA |
dc.description.abstract | Introduction: Data from Africa reporting the epidemiology of infection in hospitalised neonates are limited. Methodology: A prospective study with convenience sampling was conducted to characterise neonates investigated with blood culture/s for suspected infection at a 132-bed neonatal unit in Cape Town, South Africa (1 February-31 October 2018). Enrolled neonates were classified as having proven bloodstream infection (BSI) (blood culture-positive with a pathogen) or presumed infection (clinically suspected but blood culture-negative) or as potentially at risk of infection (maternal risk factors at birth). Results: Of 1299 hospitalised neonates with >1 blood culture sampling episode, 712 (55%) were enrolled: 126 (17.7%) had proven BSI; 299 (42%) had presumed infection and 287 (40.3%) were potentially at risk of infection. Neonates with proven BSI had lower birth weight and higher rates of co-existing surgical conditions versus the presumed/potential infection groups (p < 0.001). Median onset of proven BSI versus presumed infection was at 8 (IQR = 5-13) and 1 (IQR = 0-5) days respectively (p < 0.001). Most proven BSI were healthcare-associated (114/126; 90.5%), with Klebsiella pneumoniae (80.6% extended-spectrum β-lactamase producers) and Staphylococcus aureus (66.7% methicillin-resistant) predominating. Mortality from proven BSI (34/126; 27%) was substantially higher than that observed in presumed (8/299; 2.7%) and potential infections (3/287; 1.0%) (p < 0.001). The odds of death from proven BSI was 3-fold higher for Gram-negatives than for Gram-positive/fungal pathogens (OR = 3.23; 95% CI = 1.17-8.92). Conclusions: Proven BSI episodes were predominantly healthcare-associated and associated with a high case fatality rate. Most neonates with presumed infection or at potential risk of infection had favourable 30-day outcomes. | en_ZA |
dc.description.version | Publisher’s version | en_ZA |
dc.format.extent | 10 pages | en_ZA |
dc.identifier.citation | CITATION: Dramowski A, Bekker A, Cotton MF, Whitelaw AC, Coffin S (2021) Epidemiology of clinically suspected and laboratory-confirmed bloodstream infections at a South African neonatal unit. J Infect Dev Ctries 15:943–952. doi. 10.3855/jidc.13971 | en_ZA |
dc.identifier.issn | 1972-2680 (online) | en_ZA |
dc.identifier.uri | http://hdl.handle.net/10019.1/126670 | en_ZA |
dc.language.iso | en_ZA | en_ZA |
dc.publisher | JIDC | en_ZA |
dc.rights.holder | Authors retain copyright | en_ZA |
dc.subject | Neonatal infections -- South Africa | en_ZA |
dc.subject | Communicable diseases -- South Africa | en_ZA |
dc.subject | Bacteraemia -- South Africa | en_ZA |
dc.subject | Septicemia -- South Africa | en_ZA |
dc.subject | Anti-infective agents -- South Africa | en_ZA |
dc.title | Epidemiology of clinically suspected and laboratory-confirmed bloodstream infections at a South African neonatal unit | en_ZA |
dc.type | Article | en_ZA |